Work

Long-Term Anti-Leukemic Activity of Ponatinib in Patients with Philadelphia Chromosome-Positive Leukemia: Updated Results from an Ongoing Phase 1 Study

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.3743.3743

Authors: Michael W Deininger, Jorge E. Cortes, Hagop M. Kantarjian, Neil Shah, Dale Bixby, Michael J. Mauro, Ian W. Flinn, Thomas O'Hare, Simin Hu, David J. Dorer, Victor M. Rivera, Tim Clackson, Christopher D. Turner, Frank G Haluska, Brian J. Druker, Moshe Talpaz

Institutions: University of Utah, Huntsman Cancer Institute, The University of Texas MD Anderson Cancer Center, University of California, San Francisco, University of Michigan, U-M Rogel Cancer Center, Oregon Health & Science University, OHSU Knight Cancer Institute, Sarah Cannon, ARIAD Pharmaceuticals (United States)

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2565311549

FWCI: 0.385

Cites:

Cited by: 2

Related to: 10